ID

13597

Description

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B; ODM derived from: https://clinicaltrials.gov/show/NCT00697840

Link

https://clinicaltrials.gov/show/NCT00697840

Keywords

  1. 2/18/16 2/18/16 -
Uploaded on

February 18, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis B NCT00697840

Eligibility Hepatitis B NCT00697840

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
between 18 and 40 years old.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent will have been obtained from the subjects.
Description

written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
good physical condition as established by physical examination and history taking at the time of entry.
Description

good physical condition

Data type

boolean

Alias
UMLS CUI [1]
C1142435
female participants will avoid becoming pregnant during the study period and they will have been on a contraceptive program for at least 2 months before entry
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy or lactation.
Description

pregnancy or lactation

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
positive titres for anti hbs antibody.
Description

Hepatitis B surface antibody

Data type

boolean

Alias
UMLS CUI [1]
C0149708
any vaccination against hepatitis b in the past.
Description

Hepatitis B vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0474232
any previous administration of mpl.
Description

mpl administration

Data type

boolean

Alias
UMLS CUI [1]
C0066776
elevated serum liver enzymes.
Description

elevated serum liver enzymes

Data type

boolean

Alias
UMLS CUI [1]
C1287351
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
Description

hematologic, hepatic, renal, cardiac or respiratory disease

Data type

boolean

Alias
UMLS CUI [1]
C0009488
axillary temperature > 37.5°c at the time of injection.
Description

axillary temperature

Data type

boolean

Alias
UMLS CUI [1]
C1531924
any acute disease at the moment of entry.
Description

any acute disease

Data type

boolean

Alias
UMLS CUI [1]
C0009488
chronic alcohol consumption.
Description

chronic alcohol consumption

Data type

boolean

Alias
UMLS CUI [1]
C0038586
any treatment with immunosuppressive or immunostimulant therapy.
Description

immunosuppressive or immunostimulant

Data type

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0001551
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
Description

drug treatment precluding inclustion into study

Data type

boolean

Alias
UMLS CUI [1]
C0013216
UMLS CUI [2]
C1321605
history of allergic disease likely to be stimulated by any component of the vaccine.
Description

hypersensitivitiy to vaccine

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1521826
simultaneous administration of any other vaccine(s).
Description

simultaneous administration of any other vaccines

Data type

boolean

Alias
UMLS CUI [1]
C1321605
administration of any immunoglobulin during the study period.
Description

administration of any immunoglobulin

Data type

boolean

Alias
UMLS CUI [1]
C1321605
simultaneous participation in any other clinical trial.
Description

study participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Hepatitis B NCT00697840

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
between 18 and 40 years old.
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
written informed consent will have been obtained from the subjects.
boolean
C0021430 (UMLS CUI [1])
good physical condition
Item
good physical condition as established by physical examination and history taking at the time of entry.
boolean
C1142435 (UMLS CUI [1])
pregnancy
Item
female participants will avoid becoming pregnant during the study period and they will have been on a contraceptive program for at least 2 months before entry
boolean
C0032961 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or lactation
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hepatitis B surface antibody
Item
positive titres for anti hbs antibody.
boolean
C0149708 (UMLS CUI [1])
Hepatitis B vaccination
Item
any vaccination against hepatitis b in the past.
boolean
C0474232 (UMLS CUI [1])
mpl administration
Item
any previous administration of mpl.
boolean
C0066776 (UMLS CUI [1])
elevated serum liver enzymes
Item
elevated serum liver enzymes.
boolean
C1287351 (UMLS CUI [1])
hematologic, hepatic, renal, cardiac or respiratory disease
Item
history of significant and persisting hematologic, hepatic, renal, cardiac or respiratory disease.
boolean
C0009488 (UMLS CUI [1])
axillary temperature
Item
axillary temperature > 37.5°c at the time of injection.
boolean
C1531924 (UMLS CUI [1])
any acute disease
Item
any acute disease at the moment of entry.
boolean
C0009488 (UMLS CUI [1])
chronic alcohol consumption
Item
chronic alcohol consumption.
boolean
C0038586 (UMLS CUI [1])
immunosuppressive or immunostimulant
Item
any treatment with immunosuppressive or immunostimulant therapy.
boolean
C0021079 (UMLS CUI [1])
C0001551 (UMLS CUI [2])
drug treatment precluding inclustion into study
Item
any chronic drug treatment, which in the investigator's opinion, precludes inclusion into the study.
boolean
C0013216 (UMLS CUI [1])
C1321605 (UMLS CUI [2])
hypersensitivitiy to vaccine
Item
history of allergic disease likely to be stimulated by any component of the vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
simultaneous administration of any other vaccines
Item
simultaneous administration of any other vaccine(s).
boolean
C1321605 (UMLS CUI [1])
administration of any immunoglobulin
Item
administration of any immunoglobulin during the study period.
boolean
C1321605 (UMLS CUI [1])
study participation status
Item
simultaneous participation in any other clinical trial.
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial